HeartBeam, Inc.
BEATHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeHeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare. The $25.1M market capitalization puts BEAT squarely in micro-cap range for its industry. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms.
Market Cap
$25.1M
Beta
-0.80
P/E (TTM)
—
P/E (Fwd)
-0.84
EPS (TTM)
$-0.51
EPS (Fwd)
$-0.53
ROE
-328.4%
ROA
-153.5%
Cash
$8.7M
Total Debt
$0
Free CF
-$6.6M
52W Change
-68.8%
Annual Financials
Cash vs Debt
Where BEAT stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, BEAT finished 51.09% below its 150-day moving average ($0.92) and 61.21% below its 200-day moving average ($1.16). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BEAT overbought or oversold?
At the September 3, 2026 close, BEAT's RSI(14) was 20.1, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
HeartBeam, Inc. reports $8.7M in cash and $0 in total debt. Free cash flow is running at -$6.6M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -328.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity.
The relatively low beta of -0.80 suggests BEAT is a less volatile holding compared to the broader index. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for HeartBeam, Inc. and its sector.